Related Experiment Video
Updated: Mar 25, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Resource Effective Strategies to Prevent and Treat Cardiovascular Disease
J D Schwalm1, Martin McKee2, Mark D Huffman2
1From Population Health Research Institute and Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (J.D.S., S.Y.); Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, United Kingdom (M.M.); and Departments of Preventive Medicine and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (M.D.H.). schwalj@mcmaster.ca.
Insights
Cardiovascular disease (CVD) prevention is challenging globally, especially in low-income nations. Resource-efficient strategies targeting tobacco use, hypertension, and simplified care delivery can significantly reduce CVD mortality.
Area of Science:
- Public Health
- Cardiology
- Health Systems Research
Background:
- Cardiovascular disease (CVD) is the leading cause of global mortality.
- Prevention of CVD is suboptimal worldwide, with significant evidence-practice gaps in low- and middle-income countries.
- Barriers exist at patient, healthcare provider, and health system levels, hindering optimal CVD prevention.
Purpose of the Study:
- To identify barriers to CVD prevention in resource-constrained settings.
- To inform effective strategies for reducing CVD evidence-practice gaps.
- To highlight resource-efficient strategies for reducing premature CVD mortality.
Main Methods:
- Review of novel, resource-efficient strategies for CVD prevention.
- Focus on modifiable risk factors: tobacco use, hypertension, and secondary prevention.
- Analysis of strategies including simplified screening, cost-effective treatments, and task-sharing.
Main Results:
- Effective tobacco control measures are crucial.
- Simplified screening and management algorithms improve CVD care.
- Affordable, simplified treatment regimens and task-sharing enhance healthcare delivery.
Conclusions:
- Addressing barriers in resource-constrained settings is essential for CVD mortality reduction.
- Targeting modifiable factors like tobacco use and hypertension yields significant gains.
- Implementing these strategies can substantially reduce CVD burden and related deaths.
Abstract:
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries. The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in low- and middle-income countries. Barriers at the patient, healthcare provider, and health system level prevent the implementation of optimal primary and secondary prevention. Identification of the particular barriers that exist in resource-constrained settings is necessary to inform effective strategies to reduce the identified evidence-practice gaps. Furthermore, targeting modifiable factors that contribute most significantly to the global burden of CVD, including tobacco use, hypertension, and secondary prevention for CVD, will lead to the biggest gains in mortality reduction. We review a select number of novel, resource-efficient strategies to reduce premature mortality from CVD, including (1) effective measures for tobacco control, (2) implementation of simplified screening and management algorithms for those with or at risk of CVD, (3) increasing the availability and affordability of simplified and cost-effective treatment regimens including combination CVD preventive drug therapy, and (4) simplified delivery of healthcare through task-sharing (nonphysician health workers) and optimizing self-management (treatment supporters). Developing and deploying systems of care that address barriers related to the above will lead to substantial reductions in CVD and related mortality.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Hypertension IV: Drug Therapy and Lifestyle Modifications
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease I: Introduction

